Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) — Net Asset Momentum
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) recorded a net asset momentum of -6.0% as of December 2025, with net assets of CN¥5.66 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. For live market cap and overall valuation, see 002932 market cap.
YoY Momentum
Current Net Assets
Years of Data
Country
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A Net Asset Momentum (2011–2025)
This chart tracks Wuhan Easy Diagnosis Biomedicine Co Ltd Class A's year-over-year net asset growth across 15 annual reporting periods from 2011 to 2025. The most recent momentum reading is -6.0%, with net assets of CN¥5.66 Billion CNY as of December 2025. Check Wuhan Easy Diagnosis Biomedicine Co Ltd strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Annual Net Asset History for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (2011–2025)
The table below shows the complete annual net asset history for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A from 2011 to 2025, covering 15 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check how tangible is Wuhan Easy Diagnosis Biomedicine Co Ltd 's equity to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥5.66 Billion | CN¥5.98 Billion | CN¥324.56 Million | ▼ -6.0% |
| 2024 | CN¥6.02 Billion | CN¥6.59 Billion | CN¥574.40 Million | ▼ -4.3% |
| 2023 | CN¥6.29 Billion | CN¥7.39 Billion | CN¥1.09 Billion | ▼ -7.1% |
| 2022 | CN¥6.77 Billion | CN¥9.19 Billion | CN¥2.42 Billion | ▲ +137.6% |
| 2021 | CN¥2.85 Billion | CN¥3.42 Billion | CN¥567.02 Million | ▲ +155.6% |
| 2020 | CN¥1.11 Billion | CN¥1.43 Billion | CN¥311.77 Million | ▲ +81.1% |
| 2019 | CN¥615.62 Million | CN¥638.42 Million | CN¥22.80 Million | ▲ +3.9% |
| 2018 | CN¥592.59 Million | CN¥617.15 Million | CN¥24.55 Million | ▲ +143.9% |
| 2017 | CN¥242.93 Million | CN¥256.54 Million | CN¥13.60 Million | ▲ +38.8% |
| 2016 | CN¥175.08 Million | CN¥197.15 Million | CN¥22.07 Million | ▲ +51.7% |
| 2015 | CN¥115.39 Million | CN¥133.96 Million | CN¥18.57 Million | ▲ +132.7% |
| 2014 | CN¥49.59 Million | CN¥61.01 Million | CN¥11.42 Million | ▲ +264.7% |
| 2013 | CN¥13.60 Million | CN¥23.79 Million | CN¥10.19 Million | ▲ +855.2% |
| 2012 | CN¥1.42 Million | CN¥4.66 Million | CN¥3.23 Million | ▲ +6535.8% |
| 2011 | CN¥21.45K | CN¥1.96 Million | CN¥1.94 Million | — |